GOLDSTONE CAP (01160) plans to place a maximum of 47.4543 million shares, netting approximately HKD 20.8 million.
Jinshike Capital Group (01160) announced that on August 18, 2026 (after the trading session on the Stock Exchange), the Company entered into a placement agreement with the placing agent, whereby the placing agent agreed to act as the Company's agent on a best-efforts basis to procure not less than six subscribers (the subscribers and their ultimate beneficial owners must be independent third parties) to subscribe for a maximum of 47,454,300 placement shares, with a placing price of HKD 0.48 per placement share.
GOLDSTONE CAP (01160) announced that on August 18, 2026 (after the trading session of the Stock Exchange), the company entered into a placing agreement with the placing agent, under which the placing agent agrees to act as the company's agent on a best-efforts basis to procure not less than six placees (the placees and their ultimate beneficial owners must be independent third parties) to subscribe for a maximum of 47,454,300 placing shares at a placing price of HK$0.48 per placing share. Assuming there are no changes to the company's issued share capital from the date of this announcement to the completion date, the maximum of 47,454,300 placing shares represents (i) 20.00% of the company's existing issued share capital as of the date of this announcement; and (ii) approximately 16.67% of the company's issued share capital as enlarged by the allotment and issue of all placing shares.
Assuming all placing shares are fully placed, the total proceeds from the placing are expected to be approximately HK$22.8 million. After deducting all relevant expenses related to the placing, the net proceeds are estimated to be approximately HK$20.8 million. The company intends to use the net proceeds from the placing for general working capital and business development.
Related Articles

US Stock Market Move | The non-ferrous metal sector saw a widespread decline, with Century Aluminum Company (CENX.US) dropping over 5%.

The risks of AI ecosystem investment have been exaggerated by the market! Bank of America Corp supports NVIDIA Corporation (NVDA.US) with a target price of $350.

US Stock Market Move | Amylyx Pharmaceuticals (AMLX.US) surged nearly 51% as the Avexitide phase III LUCIDITY trial achieved its primary endpoint.
US Stock Market Move | The non-ferrous metal sector saw a widespread decline, with Century Aluminum Company (CENX.US) dropping over 5%.

The risks of AI ecosystem investment have been exaggerated by the market! Bank of America Corp supports NVIDIA Corporation (NVDA.US) with a target price of $350.

US Stock Market Move | Amylyx Pharmaceuticals (AMLX.US) surged nearly 51% as the Avexitide phase III LUCIDITY trial achieved its primary endpoint.

RECOMMEND





